Title |
The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial
|
---|---|
Published in |
Trials, May 2020
|
DOI | 10.1186/s13063-020-04407-x |
Pubmed ID | |
Authors |
Eoin Feeney, Deborah Wallace, Aoife Cotter, Willard Tinago, Cormac McCarthy, David Keane, Rabia Hussain, Elena Alvarez Barco, Peter Doran, Patrick Mallon |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Ireland | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 215 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 215 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 46 | 21% |
Other | 14 | 7% |
Researcher | 13 | 6% |
Lecturer | 7 | 3% |
Librarian | 6 | 3% |
Other | 30 | 14% |
Unknown | 99 | 46% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 37 | 17% |
Pharmacology, Toxicology and Pharmaceutical Science | 31 | 14% |
Biochemistry, Genetics and Molecular Biology | 11 | 5% |
Nursing and Health Professions | 10 | 5% |
Agricultural and Biological Sciences | 4 | 2% |
Other | 18 | 8% |
Unknown | 104 | 48% |